Related Experiment Video
Updated: Jul 4, 2025

05:49
Protein Engineering by Yeast Surface Display
Published on: November 29, 2024
1.3K
Development of Recombinant Antibody by Yeast Surface Display Technology
Mujahed I Mustafa1, Awad A Alzebair2, Ahmed Mohammed2
1Department of Biotechnology, College of Applied and Industrial Sciences, University of Bahri, Khartoum, Sudan.
Current Research in Pharmacology and Drug Discovery
|February 6, 2024
Summary
Yeast surface display is a powerful method for selecting high-affinity recombinant antibodies. This technology enables rapid generation and optimization of antibodies for therapeutic and research applications.
Area of Science:
- Biotechnology
- Molecular Biology
- Immunology
Background:
- Recombinant antibodies are essential tools in therapeutics, diagnostics, and research.
- Selecting high-affinity, specific antibodies is critical for product development.
- Yeast surface display has emerged as a robust platform for antibody selection.
Purpose of the Study:
- To provide an overview of yeast surface display technology for recombinant antibody selection.
- To discuss library construction, affinity maturation, and optimization strategies.
- To compare yeast surface display with other antibody selection methods.
Main Methods:
- Construction of yeast surface display libraries using antibody gene libraries, host strains, and display vectors.
- Application of yeast surface display for antibody affinity maturation and optimization.
- Comparative analysis of yeast surface display advantages and limitations.
Main Results:
- Yeast surface display facilitates the selection of high-affinity antibodies.
- The technology allows for efficient antibody optimization and maturation.
- It offers a versatile platform for generating recombinant antibodies.
Conclusions:
- Yeast surface display is a powerful and efficient technology for recombinant antibody selection.
- It enables the rapid generation of high-affinity antibodies for diverse applications.
- This method is valuable for advancing antibody-based therapeutics and research tools.

